Press release
Self-Expanding Stents Global Market Report 2024 by The Business Research Company | Abbott Laboratories, Medtronic PLC, Stryker Corporation, Boston Scientific Corporation, Becton, Dickinson and Company (BD Interventional), Terumo Corporation, Phenox GmbH,
The self-expanding stents market size has grown strongly in recent years. It will grow from $3.14 billion in 2023 to $3.31 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to increased awareness, growth in aging population, expansion of indications for stent usage beyond coronary arteries, growth in disposable income levels, and increased adoption of minimally invasive procedures.The self-expanding stents market size is expected to see strong growth in the next few years. It will grow to $4.17 billion in 2028 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to increasing prevalence of cardiovascular diseases, expansion of healthcare infrastructure, expansion of telemedicine services for remote consultation, growing incidence of peripheral arterial disease, and increase in the prevalence of chronic diseases. Major trends in the forecast period include technological advancements, bioresorbable stents, drug-eluting stents, minimally invasive procedures, and integration of artificial intelligence.
Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=15667&type=smp
Self-Expanding Stents Market Major Segments
The self-expanding stents market covered in this report is segmented -
1) By Product Type: Gastrointestinal Self-Expanding Stents, Carotid Self-Expanding Stents, Endovascular Self-Expandable Stents, Other Product Types
2) By Applications: Fem-Pop Artery Stents, Iliac Artery Stents, Carotid Artery Stents, Biliary Stents, Other Applications
3) By End-Users: Hospitals, Ambulatory Surgical Centers, Other End-Users
Key Driver - Expansion Of The Construction Industry To Boost Gearbox Industry Market
The growing prevalence of cardiovascular diseases is expected to propel the growth of the self-expanding stents market going forward. Cardiovascular illnesses are abnormalities of the heart and blood vessels. The growing cases of cardiovascular diseases is due to obesity, an aging population, and genetic predispositions. Self-expanding stents are useful in the therapy of cardiovascular disorders, as it provide effective and minimally invasive therapeutic alternatives for both urgent and long-term patient demands. For instance, in March 2022, according to the Office for National Statistics, a UK-based national statistical authority, the number of deaths due to heart attacks was 20,061 in 2021, increasing from 19,440 in 2020. Therefore, the growing prevalence of cardiovascular diseases is driving the growth of the self-expanding stents market.
Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=15667&type=smp
Prominent Trend - Advancements In Tracheal Stent Systems Driving Minimally Invasive Solutions
Major companies operating in the self-expanding stents market are focusing their efforts on introducing solutions, such as tracheal stent system, to reduce the need for open surgery and gain a competitive edge in the market. A tracheal stent system is a medical device used to support and maintain the patency of the trachea, often employed in cases of tracheal stenosis or collapse. For instance, in February 2022, Micro-Tech Endoscopy Inc., a US-based medical technology company, launched a tracheobronchial nitinol y-stent. It is a flexible, self-expanding stent composed of a nitinol alloy with a low-profile delivery mechanism, a silicone coating to prevent tumor ingrowth, and repositionable sutures for adjustment or removal. For individuals suffering from tracheobronchial strictures, this stent relieves symptoms by expanding the airway and enhancing airflow.
Self-Expanding Stents Market Players
Major companies operating in the self-expanding stents market are Abbott Laboratories, Medtronic PLC, Stryker Corporation, Boston Scientific Corporation, Becton, Dickinson and Company (BD Interventional), Terumo Corporation, Phenox GmbH, Balton Sp. z o.o., Biotronik SE & Co. KG, Merit Medical Systems Inc., Aesculap AG, MicroVention Inc., Lifetech Scientific Corporation, Cordis Corporation, Rontis Corporation, Veryan Medical Ltd., Andramed GmbH, Medinol Ltd., iVascular SLU, HEXACATH SAS, Eucatech AG, Endospan Ltd., Endo-Flex GmbH, Endocor GmbH
View The Full Report Here - https://www.thebusinessresearchcompany.com/report/self-expanding-stents-global-market-report
Largest And Fastest Growing Region In The Market
North America was the largest region in the self-expanding stents market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the self-expanding stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Self-Expanding Stents Market Report Structure
3. Self-Expanding Stents Market Trends And Strategies
4. Self-Expanding Stents Market - Macro Economic Scenario
5. Self-Expanding Stents Market Size And Growth
…..
27. Self-Expanding Stents Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Self-Expanding Stents Global Market Report 2024 by The Business Research Company | Abbott Laboratories, Medtronic PLC, Stryker Corporation, Boston Scientific Corporation, Becton, Dickinson and Company (BD Interventional), Terumo Corporation, Phenox GmbH, here
News-ID: 3554794 • Views: …
More Releases from the business research company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Stent
Airway Stent/Lung Stent Market: Opportunities for Future Expansion
Airway Stent/Lung Stent Market valued at USD X.X Billion in 2024 and is projected to reach USD X.X Billion by 2032, growing at a CAGR of X.X% from 2025 to 2032.
What is the Airway Stent/Lung Stent Market and Why is It Significant?
The Airway Stent/Lung Stent market involves the production and distribution of medical devices designed to support and keep open airways in patients suffering from conditions such as tracheal stenosis,…
Airway Stent Lung Stent Market Size 2024 to 2031.
Market Overview and Report Coverage
An airway stent, also known as a lung stent, is a medical device used to open up blocked airways in the lungs. It is typically used in patients with conditions such as tracheal or bronchial stenosis, tumors, or strictures. The global airway stent lung stent market is expected to grow at a CAGR of 6.10% during the forecasted period.
The future outlook for the airway stent lung…
Airway Stent and Lung Stent Market Revenue Surges: Acumen Research Projection
The airway stent/lung stent market is witnessing a significant surge in revenue, projected to increase by USD 204.4 million by 2032. This growth is driven by a Compound Annual Growth Rate (CAGR) of 6.3% from 2023 to 2032. This article delves into the various facets of the market, including regional dominance, segment growth, and the underlying factors fueling this expansion.
Market Revenue Growth
The global airway stent/lung stent market is on an…
Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P …
The latest Global Gel Stent Market research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. The Gel Stent market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market. There is wide acceptance of Gel Stent across the buyers' segments and this has been driving the…
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas …
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entire…
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients…
